Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6)	5/24/1998 8:25:00 PM
From: Anthony Wong	Respond to of 1722

Pharma scrips expected to carry on the rally Mumbai, May 22: After infotech stocks, it could now be the turn of pharma scrips. The market sees pharma companies insulated from recession, besides the dominance of MNCs in the industry. This also makes this a more investor-friendly sector and many counters in this sector are FII favourites. Analysts expect most companies in this sector to do very well and declare quite good results as compared to last year. The trend is clearly evident in the price movements of most pharma stocks. Glaxo has been seeing large volumes over the last few days. Since the beginning of the year, Pfizer has appreciated by nearly 100 per cent to the current level of Rs 659.50. SmithKline Beecham Pharma has moved from Rs 536 on January 1 to the current levels of Rs 804 while Burroughs Wellcome is still on the rise, the prices have moved from Rs 355.50 to Rs 385 levels in the last few trading sessions. indiaworld.co.in